Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: second revenue stream in the bag ??
Ok, thank you, now I understand, what you mean.
You are right, we don't know for sure, what Swartz did, so they can hold between 25mio shares and nada.
It's only my personal theory, that Swartz sold the shares after they received them from warrant-conversion.

Thanx for the clarification - gltu
Share
New Message
Please login to post a reply